Sonoma Pharmaceuticals (US:SNOA) — Company Overview, News & Financial Data
Sonoma Pharmaceuticals develops unique dermatological treatments to improve patient outcomes using technology-driven solutions.
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals (NASDAQ:SNOA) is a specialty company focused on developing and offering unique treatments for dermatological conditions and advanced tissue care. It harnesses innovative technology to create products that aim to treat infections, enhance healing, and reduce healthcare costs, tackling issues from chronic and acute wounds to various skin disorders. Sonoma's portfolio includes antimicrobial solutions based on hypochlorous acid, designed to support patients across various stages of care. The company's objective is to improve patient outcomes through high-quality, safe, and effective treatments, driving innovation in skin and wound care. With a commitment to research and development, Sonoma works on expanding its reach and impact, actively seeking to address unmet medical needs in the dermatological space.
Snapshot
Operations
Products and/or services of Sonoma Pharmaceuticals
- Hypochlorous acid (HOCl) products for dermatology, including acne, eczema, and wound care.
- Micronized HOCl for eye care, addressing conditions like blepharitis and dry eye.
- HOCl-based nasal care solutions for conditions such as sinusitis.
- Animal healthcare products leveraging HOCl for wound and skin care in pets.
- Dental rinse products designed with HOCl to improve oral health and hygiene.
- Advanced wound care dressings incorporating HOCl technology for improved healing.
Sonoma Pharmaceuticals executive team
- Ms. Amy M. Trombly Esq., J.D.CEO, President & Director
- Mr. Jerome J. Dvonch CPAChief Financial Officer
- Mr. John Dal PoggettoController